NEXGEL (NXGL) CEO sells 4,000 shares at $2.5211 under 10b5-1
NEXGEL (NXGL) reported an insider transaction on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NEXGEL (NXGL) reported an insider transaction on a Form 4. The Chief Executive Officer and Director sold 4,000 shares of common stock on 11/06/2025 at a $2.5211 weighted average price, pursuant to a Rule 10b5-1 trading plan.
Following the sale, the reporting person beneficially owns 367,692 shares, held directly. The price reflects multiple open-market sales within the $2.500–$2.5500 range.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,000 | $2.5211 | $10K |
Footnotes (2)
- F1. The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan instituted for tax planning purposes. The shares were originally acquired by the Reporting Person from the Issuer on October 15, 2019
- F2. Represents the weighted average of open market sale transactions ranging from $2.500 to $2.5500 per share. The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price sold if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NEXGEL (NXGL) disclose in this Form 4?
What is the insider’s relationship to NEXGEL (NXGL)?
What type of plan governed the sale?
Was the ownership direct or indirect?
What was the transaction code in the Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.